Clear Search sequence regions


The Polo-like kinase 1 (Plk1) is a highly conserved mitotic serine/threonine kinase which is commonly overexpressed in cancer cell lines. Plk1 positively regulates mitotic progression by activating the CDC25C-CDK1 amplification loop and by regulating late mitotic events, primarily the ubiquitin-dependent proteolysis. In the present study, an antisense strategy against Plk1 mRNA was developed to specifically inhibit cell proliferation of cancer cells in cell culture and in the nude-mouse tumor model. Among 41 phosphorothioate antisense oligodeoxynucleotides tested, the 20-mer JWG2000 strongly inhibited expression of Plk1 in cultured A549 cells, leading to loss of cell viability, and exhibited anti-tumor activity in nude mice A549 xenograft. JWG2000 did not inhibit growth and viability of primary human mesangial cells and human amnion fibroblasts. Copyright 2000 Academic Press.

Citation

R Elez, A Piiper, C D Giannini, M Brendel, S Zeuzem. Polo-like kinase1, a new target for antisense tumor therapy. Biochemical and biophysical research communications. 2000 Mar 16;269(2):352-6

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 10708555

View Full Text